STN1013800 ophthalmic solution

DRUG2 trials

Sponsors

Santen Pharmaceutical Co., Ltd.

Conditions

Blepharoptosis

Early Phase 1

A Pharmacokinetics (PK) Study in Healthy Adults

CompletedNCT06911216

Santen Pharmaceutical Co., Ltd.Blepharoptosis

Start: 2025-03-17End: 2025-04-07Updated: 2025-04-22

Phase 3

A Study in Chinese Patients With Acquired Blepharoptosis

RecruitingNCT06683651

Santen Pharmaceutical Co., Ltd.Blepharoptosis

Start: 2024-10-22End: 2026-06-01Target: 180Updated: 2026-05-15